Skip to main content
Improving health evaluations to capture wider value of therapeutics and incentivise innovation
Read on PubMed
Variations in comorbidity burden in people with type 2 diabetes over disease duration: A population-based analysis of real world evidence
Read on The Lancet
Excess mortality in England post Covid-19 pandemic: implications for secondary prevention
Read on The Lancet
The impact of the Covid-19 pandemic on cardiovascular disease prevention and corresponding geographical inequalities in England: interrupted time series analysis
Read on PMC
Value-Based Healthcare in practice: IDEATE, a collaboration to design and test an outcomes-based agreement for a medicine in Wales
Read on Research Square
Emulating trials and quantifying bias: The convergence of health technology assessment agency real-world evidence guidance
Read on Value in Health
Real world outcomes, healthcare utilisation and costs of Alzheimer's disease in England
Read on ScienceDirect
Access in all areas? A round up of developments in market access and health technology assessment
Read Part 3
Read Part 4
Jump to top